Dr. Eric Topol

The NIH part is especially a problem because we're seeing a budget being dropped down from $47 billion

by 40%, almost $20 billion less.

And one could argue that it would be good to have made it more efficient and take some of the cost of doing biomedical research in this country, the crown jewel of the world, sure, but not in a reckless, indiscriminate, and profound way.

So this is one of the big devastating parts.

But as you say, it cuts across all parts of the HHS, RFK Jr.

's history.

stewardship, and the vaccine panel is just one more.

It seems like every day there's something else to add to this that's challenging the ongoing science research in this country.

And there doesn't appear to be any good rationale, reason,

Methods are being used here.

So it's horrible.

The main question, of course, is will we still be able to go forward or are we going to basically go even backwards in terms of all the advances?

I mean, this is such a momentous time in medicine.

Of all times for this to occur, we're making such remarkable strides and it's going to set us back.

It's also going to give an advantage to other countries around the world who are not going through this.

Yeah, so this is really the reason why we're moving into this hyper-accelerated phase of discovery and transforming medicine.

For one, we're seeing the discovery of new drugs.

In fact, a drug for a very severe lung condition that we don't have a good treatment for, idiopathic pulmonary fibrosis.

This is the first AI-discovered drug that is now

passed a phase two trial, so it's pretty far along and it looks great, discovered by AI.